- Home
- SNX vs ASND Comparison
SNX vs ASND Comparison
Compare SNX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNX
- ASND
- Stock Information
- Founded
- SNX 1980
- ASND 2006
- Country
- SNX United States
- ASND Denmark
- Employees
- SNX N/A
- ASND N/A
- Industry
- SNX Retail: Computer Software & Peripheral Equipment
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- SNX Technology
- ASND Health Care
- Exchange
- SNX Nasdaq
- ASND Nasdaq
- Market Cap
- SNX 13.3B
- ASND 12.2B
- IPO Year
- SNX 2003
- ASND 2015
- Fundamental
- Price
- SNX $153.28
- ASND $197.40
- Analyst Decision
- SNX Strong Buy
- ASND Strong Buy
- Analyst Count
- SNX 10
- ASND 17
- Target Price
- SNX $169.00
- ASND $245.76
- AVG Volume (30 Days)
- SNX 567.2K
- ASND 364.4K
- Earning Date
- SNX 09-25-2025
- ASND 11-12-2025
- Dividend Yield
- SNX 1.14%
- ASND N/A
- EPS Growth
- SNX 18.98
- ASND N/A
- EPS
- SNX 9.21
- ASND N/A
- Revenue
- SNX $60,973,509,000.00
- ASND $576,332,355.00
- Revenue This Year
- SNX $7.25
- ASND $104.98
- Revenue Next Year
- SNX $4.50
- ASND $79.91
- P/E Ratio
- SNX $16.77
- ASND N/A
- Revenue Growth
- SNX 6.94
- ASND 54.50
- 52 Week Low
- SNX $92.23
- ASND $118.03
- 52 Week High
- SNX $167.76
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- SNX 51.03
- ASND 43.66
- Support Level
- SNX $148.27
- ASND $195.80
- Resistance Level
- SNX $154.53
- ASND $202.41
- Average True Range (ATR)
- SNX 3.43
- ASND 6.86
- MACD
- SNX -0.30
- ASND -1.09
- Stochastic Oscillator
- SNX 57.71
- ASND 16.96
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.